Atlas Trials

A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma

Clinical trial NCT05527275 · UNKNOWN

Trial details

NCT number
NCT05527275
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed and Refractory Peripheral T-cell Lymphoma
Start date
2022-10-01
Primary completion
2024-09-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.